Status:
COMPLETED
Isolated Glenohumeral Corticosteroid Injection Versus Concomitant Capsule Preserving Hydrodilatation
Lead Sponsor:
Chuncheon Sacred Heart Hospital
Conditions:
Adhesive Capsulitis
Adhesive Capsulitis of Shoulder
Eligibility:
All Genders
35-80 years
Phase:
NA
Brief Summary
This clinical trial investigates whether concomitant capsule-preserving hydrodilatation (CSHD) is more effective than isolated glenohumeral corticosteroid injection (CS) in treating shoulder adhesive ...
Detailed Description
A single-centre, double-blinded, prospective randomised controlled trial involving patients diagnosed with adhesive capsulitis of the shoulder (AC). Patients were randomly allocated to either cortico...
Eligibility Criteria
Inclusion
- Two or more of the following criteria within the shoulder's range of motion:
- Abduction and forward elevation below 100˚
- External rotation at the side below 30˚
- Internal rotation at 90˚ of abduction below 30˚
Exclusion
- History of shoulder surgery, trauma, nerve injury
- Concomitant rotator cuff/biceps lesions in ultrasound or MRI
- Glenohumeral arthritis in simple X-ray
- Calcific tendinosis in simple X-ray
- Underlying conditions: cancer, mental illness, hormonal imbalance
- Diabetes with HbA1c levels exceeding 7.0%
Key Trial Info
Start Date :
December 5 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 17 2015
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06493656
Start Date
December 5 2013
End Date
November 17 2015
Last Update
July 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chuncheon Sacred Heart Hospital
Chuncheon, Gangwondo, South Korea, 700-204